Mehdi Paborji, PhD

Mehdi Paborji, PhD has an extensive work experience in the pharmaceutical industry. Mehdi currently serves as the Senior Vice President and Head of Technical Operations and CMC at Rain Oncology since April 2022. Prior to this, they founded Lucidus Pharma in 2017 and has been serving as its Founder. Mehdi also worked as a Global Pharma Key Opinion Leader (Consultant) at the Korea Health Industry Development Institute (KHIDI) starting from August 2013.

From December 2019 to March 2022, Mehdi Paborji held the position of Chief Technical Officer at Valorum Biologics. Before that, they served as the Vice President of Technical Operations and CMC at Sunesis Pharmaceuticals, Inc. from November 2019 to July 2021.

During their tenure at Biotie Therapies, Inc., starting from January 2014, Mehdi Paborji worked as the Chief Operating Officer and SSF Site Head. Mehdi was responsible for various aspects of the company's operations, including Global Pharmaceutical Development, CMC, Non-clinical, Safety and Pharmacology, Clinical Supply Management, Project Management, and Inflammation Group and IP/Patent.

Earlier in their career, Mehdi Paborji founded TheraVida, Inc. in 2005 and served as its Chief Operating Officer. Mehdi also worked at Theravance as a Sr. Director from 2001 to 2004, and at Bristol-Myers Squibb as a Director from 1986 to 2001.

Mehdi Paborji, PhD has an education history that includes obtaining a PhD in Bio-Organic and Physical Organic Chemistry from The University of Kansas. Additionally, Paborji pursued further studies and completed a Post-Doc in Pharmaceutical Chemistry at The University of Kansas. However, specific start and end years for each degree were not provided.